ÂÜÀòÂÒÂ×

Adam Chopko is an accomplished professional in business development and corporate strategy, currently serving as Vice President of Business Development at Teladoc Health since October 2020, following the merger with Livongo. Previously, Adam held the role of Senior Director of Business Development and Strategy at Livongo, where significant contributions were made to corporate development and M&A transactions during the company's rapid growth. Adam's experience includes leading strategic partnerships, executing multiple acquisitions, and managing post-merger integrations. Prior roles include Director of Business Development and Product Marketing at Integrated Plasmonics Corporation and Senior Consultant at Monitor Deloitte. Adam holds an MBA from the University of California, Berkeley, where achievement included graduating with highest honors, and a Bachelor of Science in Chemistry and Economics from Duke University.